Glioma Imaging: A Road Map to Standardized Imaging

HomeRadiologyVol. 313, No. 3 PreviousNext Reviews and CommentaryEditorialGlioma Imaging: A Road Map to Standardized ImagingKeith R. Peters Keith R. Peters Author AffiliationsFrom the Department of Radiology, University of Florida College of Medicine, 1600 SW Archer Rd, Gainesville, FL 32610.Address correspondence to the author (email: [email protected]).Keith R. Peters Published Online:Dec 10 2024https://doi.org/10.1148/radiol.241235See also the article by Shiroshi and Erickson et al in this issue.MoreSectionsFull textPDF ToolsAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookXLinked In References1. Shiroishi MS, Erickson BJ, Hu LS, et al. The QIBA Profile for Dynamic Susceptibility Contrast MRI Quantitative Imaging Biomarkers for Assessing Gliomas. Radiology 2024;313(3):e232555. Google Scholar2. Welker K, Boxerman J, Kalnin A, Kaufmann T, Shiroishi M, Wintermark M; American Society of Functional Neuroradiology MR Perfusion Standards and Practice Subcommittee of the ASFNR Clinical Practice Committee. ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain. AJNR Am J Neuroradiol 2015;36(6):E41–E51. Medline Google Scholar3. De Simone M, Conti V, Palermo G, De Maria L, Iaconetta G. Advancements in Glioma Care: Focus on Emerging Neurosurgical Techniques. Biomedicines 2023;12(1):8. Medline Google Scholar4. Johnson DR, Giannini C, Vaubel RA, et al. A Radiologist's Guide to the 2021 WHO Central Nervous System Tumor Classification: Part I-Key Concepts and the Spectrum of Diffuse Gliomas. Radiology 2022;304(3):494–508. Google Scholar5. Zikou A, Sioka C, Alexiou GA, Fotopoulos A, Voulgaris S, Argyropoulou MI. Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas. Contrast Media Mol Imaging 2018;2018:6828396. Medline Google Scholar6. Patel P, Baradaran H, Delgado D, et al. MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis. Neuro-oncol 2017;19(1):118–127. Medline Google Scholar7. Prah MA, Stufflebeam SM, Paulson ES, et al. Repeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed Glioblastoma. AJNR Am J Neuroradiol 2015;36(9):1654–1661. Medline Google ScholarArticle HistoryReceived: Apr 25 2024Revision requested: May 5 2024Revision received: May 23 2024Accepted: May 24 2024Published online: Dec 10 2024 FiguresReferencesRelatedDetailsAccompanying This ArticleThe QIBA Profile for Dynamic Susceptibility Contrast MRI Quantitative Imaging Biomarkers for Assessing GliomasDec 10 2024Radiology Vol. 313, No. 3 Metrics Altmetric Score PDF download